Klinikum Nürnberg — Klinik für Psychiatrie und Psychotherapie (Campus Nord)

Treatment & access

• Treatments offeredEsketamine nasal spray (Spravato®)
• Access routeCovered by a national programme
• Cost & coverage (registry status)Covered by GKV for on-label TRD; see country guide
• ReimbursementGKV, hospital financing for day-clinic/inpatient induction; outpatient maintenance via PIA Campus Nord for up to 6 months How reimbursement works in Europe →
• Phone+49 911 398-9074
• Websitehttps://www.klinikum-nuernberg.de/behandlung/seelische-gesundheit/

About this provider

Klinikum Nürnberg is one of Europe's largest municipal hospitals and a teaching hospital of Paracelsus Medical University. Its Department of Psychiatry and Psychotherapy at Campus Nord publishes a referrer newsletter on its own domain that sets out a formal Spravato pathway: intranasal esketamine delivered in a day-clinic or inpatient setting over three to six weeks, followed where successful by outpatient maintenance for up to six months through the hospital's psychiatric institute outpatient clinic (PIA). A dedicated referral phone line and email are published.

Common questions

What to prepare before you enquire

• A referral or the contact details of your treating clinician
• A list of medications you have tried (names, doses, duration)
• A short diagnosis summary or discharge letters

Esketamine programmes usually require a documented history of antidepressant treatment.

Send documents directly to the provider when they reply. We never ask you to upload medical records.